Dr. Joseph Jurcic specializes in the research of acute myeloid leukemia, radioimmunotherapy with alpha and beta particle-emitting radioisotopes, monoclonal antibody therapy for leukemia, and the molecular monitoring of minimal residual disease. His work focuses on the treatment of acute and chronic leukemias, myeloproliferative neoplasms, and myelodysplastic syndrome. He received the 2001 Louis and Allston Boyer Young Investigator Award for Distinguished Achievement in Biomedical Research from Memorial Sloan-Kettering Cancer Center. Dr. Jurcic is currently Professor of Medicine at Columbia University Medical Center and Director of the Hematologic Malignancies Section of the Division of Hematology/Oncology with over 80 articles and book chapters to his name.